Filter
59
Featured
Recommendations
3
New Publications
4
Language
Document type
No document type
58
Guidelines
1
Countries / Regions
Africa
4
India
3
Latin America and the Carribbean
2
Nigeria
1
China
1
Brazil
1
Ukraine
1
Chile
1
South–East Asia Region
1
Eastern Europe
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
3
Women & Child Health
1
Epilepsy: a public health imperative
recommended
This is the first global report on epilepsy summarizing the available evidence on the burden of epilepsy and the public health response required at global, regional and national levels.
The reports highlights major gaps in awareness, diagnosis, treatment, and health policies through a series of a
...
Accessed: 10.03.2019
Accessed: 10.03.2019
mhGAP Training Manual for the mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings – version 2.0 (for field testing)
7 February 2019
Lancet Neurol. 2019 Apr;18(4):357-375. doi: 10.1016/S1474-4422(18)30454-X. Epub 2019 Feb 14.
8 février 2018
SIGN 143. A national clinical guideline
Published May 2015, Revised 2018
The Guide
Por el Sendero de Epilepsia Ges 2016 Niños y Adultos
Clasificación de las Crisis
SCOPING QUESTION: In adults with acute convulsive seizures, where intravenous access is available, which first-line anti- epileptic medication should be used to abort seizures when compared to comparator?
SCOPING QUESTION: For adults and children with medication-resistant convulsive epilepsy, which anti-epileptic medications produce benefits and/or harm in the specified outcomes when compared to a placebo or a comparator?
This is the fifteenth edition of the lecture notes. They were first published in 1987 as a summary of the material used in the biannual epilepsy teaching weekend organised under the auspices of the UK Chapter of the International League against Epilepsy.
(Lecture series consist of a total of 59 cha
...
[Updated 2015]
Scoping Question: In adults with acute convulsive seizures in first-level care or in the community (when no IV access is available), which antiepileptic medications produce benefits and/or harm when compared to comparator?
